Galmed Pharmaceuticals (GLMD) Other Operating Expenses (2013 - 2024)
Galmed Pharmaceuticals (GLMD) recorded quarterly Other Operating Expenses of -$97000.0 in Q3 2024, down 2040.0% quarter-over-quarter from $5000.0 in Q3 2023, and down 2040.0% on a YoY basis from $5000.0 in Q4 2023.
Galmed Pharmaceuticals (GLMD) Other Operating Expenses (2013 - 2024) Analysis & Trends
Galmed Pharmaceuticals' Other Operating Expenses history runs 8 years deep, the most recent figure standing at -$97000.0 for Q3 2024.
- In Q3 2024, Other Operating Expenses fell 2040.0% year-over-year to -$97000.0; the TTM figure through Jun 2025 stood at -$97000.0 (down 2040.0% YoY), while the FY2020 annual figure was -$1.0 million, down 35.6% from the prior year.
- Other Operating Expenses was -$97000.0 for Q3 2024 at Galmed Pharmaceuticals, down from $5000.0 in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $51000.0 in Q1 2022 to a low of -$278000.0 in Q2 2023.
- Historically, Other Operating Expenses has averaged -$89100.0 across 4 years, with a median of -$63500.0 in 2022.
- The sharpest annual moves came in 2022 and 2023: Other Operating Expenses soared 125.0% in 2022, then slumped 7050.0% in 2023.
- A 4-year view of Other Operating Expenses shows it stood at -$131000.0 in 2021, then jumped by 77.1% to -$30000.0 in 2022, then jumped by 116.67% to $5000.0 in 2023, then slumped by 2040.0% to -$97000.0 in 2024.
- The last three Other Operating Expenses figures came in at -$97000.0 (Q3 2024), $5000.0 (Q3 2023), and -$278000.0 (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Galmed Pharmaceuticals | 2.48 Mn | -1.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -97,000.00 |
| Sep 30, 2023 | 5,000.00 |
| Jun 30, 2023 | -278,000.00 |
| Mar 31, 2023 | -172,000.00 |
| Sep 30, 2022 | -30,000.00 |
| Jun 30, 2022 | 4,000.00 |
| Mar 31, 2022 | 51,000.00 |
| Sep 30, 2021 | -131,000.00 |
| Jun 30, 2021 | -16,000.00 |
| Mar 31, 2021 | -227,000.00 |
| Sep 30, 2018 | -1.50 Mn |
| Jun 30, 2018 | -270,000.00 |
| Mar 31, 2018 | -268,000.00 |
| Dec 31, 2017 | -274,000.00 |
| Sep 30, 2017 | -273,000.00 |
| Jun 30, 2017 | -270,000.00 |
| Mar 31, 2017 | -268,000.00 |
| Dec 31, 2016 | -274,000.00 |
| Sep 30, 2016 | -193,000.00 |
| Mar 31, 2013 | 10,000.00 |